ConceptID | Lang | Dictionary | Term |
---|
C0003333 | FRE | MSHFRE | Antigène de Hanganutziu-Deicher |
C0003333 | FRE | MSHFRE | Antigène de Paul-Bunnell |
C0003333 | FRE | MSHFRE | Xénoantigènes |
C0003333 | FRE | MSHFRE | Hétéroantigènes |
C0003333 | FRE | MSHFRE | Antigènes xénogéniques |
C0003333 | FRE | MSHFRE | Antigènes hétérogénétiques |
C0003333 | FRE | MSHFRE | Antigènes hétérophiles |
C0003333 | FRE | MSHFRE | Antigène hétérophile |
C0003333 | FRE | MSHFRE | Antigène HD |
C0003333 | FRE | MSHFRE | Antigène xénogénique |
C0003333 | FRE | MSHFRE | Antigènes hétérologues |
C0003333 | FRE | MSHFRE | Antigène H-D |
C0003333 | FRE | MSHFRE | Antigène de Hanganutziu-Deicher |
C0003333 | FRE | MSHFRE | Antigène de Paul-Bunnell |
C0003333 | FRE | MSHFRE | Xénoantigènes |
C0003333 | FRE | MSHFRE | Hétéroantigènes |
C0003333 | FRE | MSHFRE | Antigènes xénogéniques |
C0003333 | FRE | MSHFRE | Antigènes hétérogénétiques |
C0003334 | FRE | MSHFRE | Antigènes Ly |
C0003334 | FRE | MSHFRE | Antigène Ly |
C0003334 | FRE | MSHFRE | Antigènes Ly |
C0003334 | FRE | MSHFRE | Antigène Ly |
C0003335 | FRE | MSHFRE | Antigènes néoplasiques |
C0003335 | FRE | MSHFRE | Antigène tumoral |
C0003335 | FRE | MSHFRE | Antigène de tumeur |
C0003335 | FRE | MSHFRE | Antigènes néoplasiques |
C0003335 | FRE | MSHFRE | Antigène tumoral |
C0003335 | FRE | MSHFRE | Antigène de tumeur |
C0003336 | FRE | MSHFRE | Antigène PC-1 des plasmocytes |
C0003336 | FRE | MSHFRE | Antigène PC-1 des cellules plasmocytaires |
C0003336 | FRE | MSHFRE | Antigène PC1 des plasmocytes |
C0003336 | FRE | MSHFRE | Antigène PC-1 des plasmocytes |
C0003336 | FRE | MSHFRE | Antigène PC-1 des cellules plasmocytaires |
C0003336 | FRE | MSHFRE | Antigène PC1 des plasmocytes |
C0003337 | FRE | MSHFRE | Antigènes du polyomavirus |
C0003337 | FRE | MSHFRE | Antigènes du polyomavirus |
C0003338 | FRE | MSHFRE | Antigènes de protozoaire |
C0003338 | FRE | MSHFRE | Antigènes des protozoaires |
C0003338 | FRE | MSHFRE | Antigènes de protozoaire |
C0003338 | FRE | MSHFRE | Antigènes des protozoaires |
C0003339 | FRE | MSHFRE | Antigènes de surface |
C0003339 | FRE | MSHFRE | Antigènes de surface cellulaire |
C0003339 | FRE | MSHFRE | Antigène de surface |
C0003339 | FRE | MSHFRE | Marqueurs immunologiques de surface |
C0003339 | FRE | MSHFRE | Antigènes de surface |
C0003339 | FRE | MSHFRE | Antigènes de surface cellulaire |
C0003339 | FRE | MSHFRE | Antigène de surface |
C0003339 | FRE | MSHFRE | Marqueurs immunologiques de surface |
C0003340 | FRE | MSHFRE | Antigènes thymo-indépendants |
C0003340 | FRE | MSHFRE | Antigène thymo-indépendant |
C0003340 | FRE | MSHFRE | Antigènes T-indépendants |
C0003340 | FRE | MSHFRE | Antigènes indépendants du thymus |
C0003340 | FRE | MSHFRE | Antigènes thymo-indépendants |
C0003340 | FRE | MSHFRE | Antigène thymo-indépendant |
C0003340 | FRE | MSHFRE | Antigènes T-indépendants |
C0003340 | FRE | MSHFRE | Antigènes indépendants du thymus |
C0003341 | FRE | MSHFRE | Antigènes glycanniques associés aux tumeurs |
C0003341 | FRE | MSHFRE | Antigènes glycanniques associés aux tumeurs malignes |
C0003341 | FRE | MSHFRE | Antigènes glycanniques associés aux cancers |
C0003341 | FRE | MSHFRE | Antigène carbohydrate |
C0003341 | FRE | MSHFRE | Épitectine |
C0003341 | FRE | MSHFRE | Antigènes CA |
C0003341 | FRE | MSHFRE | Antigènes associés aux carcinomes |
C0003341 | FRE | MSHFRE | Antigène CA |
C0003341 | FRE | MSHFRE | Antigènes glucidiques associés aux cancers |
C0003341 | FRE | MSHFRE | Antigènes glucidiques associés aux tumeurs malignes |
C0003341 | FRE | MSHFRE | Antigènes carbohydrates associés aux tumeurs malignes |
C0003341 | FRE | MSHFRE | Antigènes glucidiques associés aux tumeurs |
C0003341 | FRE | MSHFRE | Antigènes carbohydrates associé aux cancers |
C0003341 | FRE | MSHFRE | Antigènes glycanniques associés aux tumeurs |
C0003341 | FRE | MSHFRE | Antigènes glycanniques associés aux tumeurs malignes |
C0003341 | FRE | MSHFRE | Antigènes glycanniques associés aux cancers |
C0003341 | FRE | MSHFRE | Antigène carbohydrate |
C0003341 | FRE | MSHFRE | Épitectine |
C0003341 | FRE | MSHFRE | Antigènes CA |
C0003341 | FRE | MSHFRE | Antigènes associés aux carcinomes |
C0003341 | FRE | MSHFRE | Antigène CA |
C0003341 | FRE | MSHFRE | Antigènes glucidiques associés aux cancers |
C0003341 | FRE | MSHFRE | Antigènes glucidiques associés aux tumeurs malignes |
C0003341 | FRE | MSHFRE | Antigènes carbohydrates associés aux tumeurs malignes |
C0003341 | FRE | MSHFRE | Antigènes glucidiques associés aux tumeurs |
C0003341 | FRE | MSHFRE | Antigènes carbohydrates associé aux cancers |
C0003342 | FRE | MSHFRE | Antigènes viraux |
C0003342 | FRE | MSHFRE | Antigène viral |
C0003342 | FRE | MSHFRE | Antigènes viraux |
C0003342 | FRE | MSHFRE | Antigène viral |
C0003343 | FRE | MSHFRE | Antigènes des virus oncogènes |
C0003343 | FRE | MSHFRE | Antigène viral tumoral |
C0003343 | FRE | MSHFRE | Antigène T viral |
C0003343 | FRE | MSHFRE | Antigène de virus oncogène |
C0003343 | FRE | MSHFRE | Antigènes viraux tumoraux |
C0003343 | FRE | MSHFRE | Antigènes T viraux |
C0003343 | FRE | MSHFRE | Antigènes des virus oncogènes |
C0003343 | FRE | MSHFRE | Antigène viral tumoral |
C0003343 | FRE | MSHFRE | Antigène T viral |
C0003343 | FRE | MSHFRE | Antigène de virus oncogène |
C0003343 | FRE | MSHFRE | Antigènes viraux tumoraux |
C0003343 | FRE | MSHFRE | Antigènes T viraux |
C0003353 | FRE | MSHFRE | Antigua |
C0003353 | FRE | MSHFRE | Antigoa |
C0003353 | FRE | MSHFRE | Antigua |
C0003353 | FRE | MSHFRE | Antigoa |
C0003354 | FRE | MSHFRE | Antigua-et-Barbuda |
C0003354 | FRE | MSHFRE | Barbuda et Antigua |
C0003354 | FRE | MSHFRE | Antigua-et-Barbuda |
C0003354 | FRE | MSHFRE | Barbuda et Antigua |
C0003364 | FRE | MSHFRE | Antihypertenseurs |
C0003364 | FRE | MSHFRE | Anti-hypertenseurs |
C0003364 | FRE | MSHFRE | Médicaments antihypertenseurs |
C0003364 | FRE | MSHFRE | Agents antihypertenseurs |
C0003364 | FRE | MSHFRE | Antihypertenseurs |
C0003364 | FRE | MSHFRE | Anti-hypertenseurs |
C0003364 | FRE | MSHFRE | Médicaments antihypertenseurs |
C0003364 | FRE | MSHFRE | Agents antihypertenseurs |
C0003368 | FRE | MSHFRE | Globulines antilymphoblastes |
C0003368 | FRE | MSHFRE | Globulines anti-lymphoblastes |
C0003368 | FRE | MSHFRE | Globulines antilymphoblastes |
C0003368 | FRE | MSHFRE | Globulines anti-lymphoblastes |
C0003369 | FRE | MSHFRE | Anticorps antilymphocytaires |
C0003369 | FRE | MSHFRE | Anticorps antilymphocyte |
C0003369 | FRE | MSHFRE | Anticorps anti-lymphocytaires |
C0003369 | FRE | MSHFRE | Anticorps antilymphocytes |
C0003369 | FRE | MSHFRE | Anticorps anti-lymphocytes |
C0003369 | FRE | MSHFRE | Anticorps antilymphocytaire |
C0003369 | FRE | MSHFRE | Anticorps antilymphocytaires |
C0003369 | FRE | MSHFRE | Anticorps antilymphocyte |
C0003369 | FRE | MSHFRE | Anticorps anti-lymphocytaires |
C0003369 | FRE | MSHFRE | Anticorps antilymphocytes |
C0003369 | FRE | MSHFRE | Anticorps anti-lymphocytes |
C0003369 | FRE | MSHFRE | Anticorps antilymphocytaire |
C0003370 | FRE | MSHFRE | Globuline antilymphocytaire |
C0003370 | FRE | MSHFRE | Globuline anti-lymphocytaire |
C0003370 | FRE | MSHFRE | Globuline antilymphocytaire |
C0003370 | FRE | MSHFRE | Globuline anti-lymphocytaire |
C0003371 | FRE | MSHFRE | Immunoglobuline antilymphocyte |
C0003371 | FRE | MSHFRE | Immunoglobuline antilymphocytaire |
C0003371 | FRE | MSHFRE | Immunoglobuline anti-lymphocyte |
C0003371 | FRE | MSHFRE | Immunoglobuline antilymphocytes |
C0003371 | FRE | MSHFRE | Immunoglobuline antilymphocyte |
C0003371 | FRE | MSHFRE | Immunoglobuline antilymphocytaire |
C0003371 | FRE | MSHFRE | Immunoglobuline anti-lymphocyte |
C0003371 | FRE | MSHFRE | Immunoglobuline antilymphocytes |
C0003372 | FRE | MSHFRE | Sérum antilymphocyte |
C0003372 | FRE | MSHFRE | Sérum antilymphocytaire |
C0003372 | FRE | MSHFRE | Sérum antilymphocytes |
C0003372 | FRE | MSHFRE | SAL (Sérum AntiLymphocytaire) |
C0003372 | FRE | MSHFRE | Sérum anti-lymphocytes |
C0003372 | FRE | MSHFRE | Sérum anti-lymphocytaire |
C0003372 | FRE | MSHFRE | Sérum anti-lymphocyte |
C0003372 | FRE | MSHFRE | Sérum antilymphocyte |
C0003372 | FRE | MSHFRE | Sérum antilymphocytaire |
C0003372 | FRE | MSHFRE | Sérum antilymphocytes |
C0003372 | FRE | MSHFRE | SAL (Sérum AntiLymphocytaire) |
C0003372 | FRE | MSHFRE | Sérum anti-lymphocytes |
C0003372 | FRE | MSHFRE | Sérum anti-lymphocytaire |
C0003372 | FRE | MSHFRE | Sérum anti-lymphocyte |
C0003374 | FRE | MSHFRE | Antipaludiques |
C0003374 | FRE | MSHFRE | Antimalariques |
C0003374 | FRE | MSHFRE | Antipaludéens |
C0003374 | FRE | MSHFRE | Agents antipaludiques |
C0003374 | FRE | MSHFRE | Anti-paludéens |
C0003374 | FRE | MSHFRE | Médicaments antipaludiques |
C0003374 | FRE | MSHFRE | Anti-malariques |
C0003374 | FRE | MSHFRE | Anti-paludiques |
C0003374 | FRE | MSHFRE | Antipaludiques |
C0003374 | FRE | MSHFRE | Antimalariques |
C0003374 | FRE | MSHFRE | Antipaludéens |
C0003374 | FRE | MSHFRE | Agents antipaludiques |
C0003374 | FRE | MSHFRE | Anti-paludéens |
C0003374 | FRE | MSHFRE | Médicaments antipaludiques |
C0003374 | FRE | MSHFRE | Anti-malariques |
C0003374 | FRE | MSHFRE | Anti-paludiques |
C0003376 | FRE | MSHFRE | Antimétabolites |
C0003376 | FRE | MSHFRE | Antimétabolites |
C0003377 | FRE | MSHFRE | Antinéoplasiques antimétabolites |
C0003377 | FRE | MSHFRE | Antimétabolites antinéoplasiques |
C0003377 | FRE | MSHFRE | Anticancéreux antimétabolites |
C0003377 | FRE | MSHFRE | Antinéoplasiques antimétabolites |
C0003377 | FRE | MSHFRE | Antimétabolites antinéoplasiques |
C0003377 | FRE | MSHFRE | Anticancéreux antimétabolites |
C0003379 | FRE | MSHFRE | Antimitotiques |
C0003379 | FRE | MSHFRE | Agents antimitotiques |
C0003379 | FRE | MSHFRE | Anti-mitotiques |
C0003379 | FRE | MSHFRE | Médicaments antimitotiques |
C0003379 | FRE | MSHFRE | Antimitotiques |
C0003379 | FRE | MSHFRE | Agents antimitotiques |
C0003379 | FRE | MSHFRE | Anti-mitotiques |
C0003379 | FRE | MSHFRE | Médicaments antimitotiques |
C0003380 | FRE | MSHFRE | Antimoine |
C0003380 | FRE | MSHFRE | Antimoine |
C0003382 | FRE | MSHFRE | Tartrate de potassium d`antimoine |
C0003382 | FRE | MSHFRE | Tartrate potassique d`antimoine |
C0003382 | FRE | MSHFRE | Tartrate de potassium d`antimoine |
C0003382 | FRE | MSHFRE | Tartrate potassique d`antimoine |
C0003383 | FRE | MSHFRE | Gluconate de sodium d`antimoine |
C0003383 | FRE | MSHFRE | Gluconate sodique d`antimoine |
C0003383 | FRE | MSHFRE | Gluconate de sodium d`antimoine |
C0003383 | FRE | MSHFRE | Gluconate sodique d`antimoine |
C0003385 | FRE | MSHFRE | Antagonistes muscariniques |
C0003385 | FRE | MSHFRE | Anti-muscariniques |
C0003385 | FRE | MSHFRE | Antimuscariniques |
C0003385 | FRE | MSHFRE | Médicaments antimuscariniques |
C0003385 | FRE | MSHFRE | Agents antimuscariniques |
C0003385 | FRE | MSHFRE | Antagonistes muscariniques |
C0003385 | FRE | MSHFRE | Anti-muscariniques |
C0003385 | FRE | MSHFRE | Antimuscariniques |
C0003385 | FRE | MSHFRE | Médicaments antimuscariniques |
C0003385 | FRE | MSHFRE | Agents antimuscariniques |
C0003387 | FRE | MSHFRE | Antimycine A |
C0003387 | FRE | MSHFRE | Antimycine A |
C0003390 | FRE | MSHFRE | Politique antinataliste |
C0003390 | FRE | MSHFRE | Politique antinataliste |
C0003391 | FRE | MSHFRE | Antihelminthiques antinématodes |
C0003391 | FRE | MSHFRE | Nématocides |
C0003391 | FRE | MSHFRE | Médicaments antinématodes |
C0003391 | FRE | MSHFRE | Agents antinématodes |
C0003391 | FRE | MSHFRE | Antihelminthiques antinématodes |
C0003391 | FRE | MSHFRE | Nématocides |
C0003391 | FRE | MSHFRE | Médicaments antinématodes |
C0003391 | FRE | MSHFRE | Agents antinématodes |
C0003392 | FRE | MSHFRE | Antinéoplasiques |
C0003392 | FRE | MSHFRE | Anticancéreux |
C0003392 | FRE | MSHFRE | Agents antinéoplasiques |
C0003392 | FRE | MSHFRE | Médicaments anticancéreux |
C0003392 | FRE | MSHFRE | Médicaments antinéoplasiques |
C0003392 | FRE | MSHFRE | Agents anticancéreux |
C0003392 | FRE | MSHFRE | Agents antitumoraux |
C0003392 | FRE | MSHFRE | Médicaments antitumoraux |
C0003392 | FRE | MSHFRE | Antitumoraux |
C0003392 | FRE | MSHFRE | Antinéoplasiques |
C0003392 | FRE | MSHFRE | Anticancéreux |
C0003392 | FRE | MSHFRE | Agents antinéoplasiques |
C0003392 | FRE | MSHFRE | Médicaments anticancéreux |
C0003392 | FRE | MSHFRE | Médicaments antinéoplasiques |
C0003392 | FRE | MSHFRE | Agents anticancéreux |
C0003392 | FRE | MSHFRE | Agents antitumoraux |
C0003392 | FRE | MSHFRE | Médicaments antitumoraux |
C0003392 | FRE | MSHFRE | Antitumoraux |
C0003393 | FRE | MSHFRE | Protocoles de polychimiothérapie antinéoplasique |
C0003393 | FRE | MSHFRE | Polychimiothérapie |
C0003393 | FRE | MSHFRE | Association d`anticancéreux |
C0003393 | FRE | MSHFRE | Protocoles de polychimiothérapie anticancéreuse |
C0003393 | FRE | MSHFRE | Protocoles de polychimiothérapie antimitotique |
C0003393 | FRE | MSHFRE | Polychimiothérapie anticancéreuse |
C0003393 | FRE | MSHFRE | Protocoles de polychimiothérapie antitumorale |
C0003393 | FRE | MSHFRE | Chimiothérapie anticancéreuse combinée |
C0003393 | FRE | MSHFRE | Polychimiothérapie antitumorale |
C0003393 | FRE | MSHFRE | Protocoles de polychimiothérapie antinéoplasique |
C0003393 | FRE | MSHFRE | Polychimiothérapie |
C0003393 | FRE | MSHFRE | Association d`anticancéreux |
C0003393 | FRE | MSHFRE | Protocoles de polychimiothérapie anticancéreuse |
C0003393 | FRE | MSHFRE | Protocoles de polychimiothérapie antimitotique |
C0003393 | FRE | MSHFRE | Polychimiothérapie anticancéreuse |
C0003393 | FRE | MSHFRE | Protocoles de polychimiothérapie antitumorale |
C0003393 | FRE | MSHFRE | Chimiothérapie anticancéreuse combinée |
C0003393 | FRE | MSHFRE | Polychimiothérapie antitumorale |
C0003394 | FRE | MSHFRE | Antinéoplasiques d`origine végétale |
C0003394 | FRE | MSHFRE | Antinéoplasiques phytogènes |
C0003394 | FRE | MSHFRE | Anticancéreux phytogènes |
C0003394 | FRE | MSHFRE | Antinéoplasiques d`origine végétale |
C0003394 | FRE | MSHFRE | Antinéoplasiques phytogènes |
C0003394 | FRE | MSHFRE | Anticancéreux phytogènes |
C0003402 | FRE | MSHFRE | Antioxydants |
C0003402 | FRE | MSHFRE | Antioxygènes |
C0003402 | FRE | MSHFRE | Agents antioxydants |
C0003402 | FRE | MSHFRE | Médicaments antioxydants |
C0003402 | FRE | MSHFRE | Anti-oxydants |
C0003402 | FRE | MSHFRE | Anti-oxygènes |
C0003402 | FRE | MSHFRE | Antioxydants |
C0003402 | FRE | MSHFRE | Antioxygènes |
C0003402 | FRE | MSHFRE | Agents antioxydants |
C0003402 | FRE | MSHFRE | Médicaments antioxydants |
C0003402 | FRE | MSHFRE | Anti-oxydants |
C0003402 | FRE | MSHFRE | Anti-oxygènes |
C0003403 | FRE | MSHFRE | Antipaïne |
C0003403 | FRE | MSHFRE | Antipain |
C0003403 | FRE | MSHFRE | Antipaïne |
C0003403 | FRE | MSHFRE | Antipain |
C0003404 | FRE | MSHFRE | Antiparasitaires |
C0003404 | FRE | MSHFRE | Parasiticides |
C0003404 | FRE | MSHFRE | Anti-parasitaires |
C0003404 | FRE | MSHFRE | Agents antiparasitaires |
C0003404 | FRE | MSHFRE | Médicaments antiparasitaires |
C0003404 | FRE | MSHFRE | Antiparasitaires |
C0003404 | FRE | MSHFRE | Parasiticides |
C0003404 | FRE | MSHFRE | Anti-parasitaires |
C0003404 | FRE | MSHFRE | Agents antiparasitaires |
C0003404 | FRE | MSHFRE | Médicaments antiparasitaires |
C0003405 | FRE | MSHFRE | Antiparkinsoniens |
C0003405 | FRE | MSHFRE | Agents antiparkinsoniens |
C0003405 | FRE | MSHFRE | Anti-parkinsoniens |
C0003405 | FRE | MSHFRE | Médicaments antiparkinsoniens |
C0003405 | FRE | MSHFRE | Antiparkinsoniens |
C0003405 | FRE | MSHFRE | Agents antiparkinsoniens |
C0003405 | FRE | MSHFRE | Anti-parkinsoniens |
C0003405 | FRE | MSHFRE | Médicaments antiparkinsoniens |
C0003410 | FRE | MSHFRE | alpha-2-Antiplasmine |
C0003410 | FRE | MSHFRE | Serpine F2 |
C0003410 | FRE | MSHFRE | alpha2-Antiplasmine |
C0003410 | FRE | MSHFRE | Inhibiteur de l`alpha-2-Plasmine |